Page 56 - Read Online
P. 56

Editorial




          The evolving role of laparoscopic ablation
          The evolving role of laparoscopic ablation

          Joseph F. Buell

          Tulane Transplant Institute,   Tulane University, New Orleans, LA 70118, USA


          Address for correspondence:
          Address for correspondence:
          Prof. Joseph F. Buell, Tulane Transplant Institute, Tulane University, New Orleans, LA 70118, USA. E-mail: jbuell1@tulane.edu
          Received: 10-06-2015, Accepted: 17-06-2015


          In the last two decades, the etiology of hepatocellular cancer   Surgical ablation initially was hampered by technologic
          has shifted from hepatitis B to hepatitis C with the incidence   limitations. This included liver fracture and profuse bleeding
          of nonalcoholic steatohepatitis (    NASH) rising dramatically.   associated with cryotherapy, and prolonged treatment
          This sudden rise in NASH and newly diagnosed cases of   times and patient hyperthermia with radiofrequency
          hepatocellular cancer may represent the tip of an epidemic.   ablation. Radiofrequency ablation with its slow thermal
          Current recommendations for patients with chronic hepatitis B   evolution was susceptible to heat sink and inadequate
          or hepatitis C infections should be screened with routine use   ablations. The most recent evolution in ablation was the
          of ultrasound. Despite this   Surveillance, Epidemiology, and   development of microwave ablation. Microwave catheters
          End Results, data would suggest that the average size of newly   were designed to decrease treatment times and overcome
          diagnosed hepatocellular cancer is beyond the Milan criteria   thermal sinks.
          at the time of diagnosis. In the setting of fatty liver disease
          and NASH, an early serologic diagnosis is not evident.  Despite the improved treatment capacity, microwave
                                                              catheters create more oblong ablation cavities. The treatment
          Significant limitations already exist in the availability of liver   areas are not exact with potential marginal recurrence from
          allografts for liver transplantation. This constraint in organ   inadequate ablations. Next generation microwave catheters
          availability necessitates improved loco-regional therapies.   are being designed to generate uniform ablation defects.
          Open and laparoscopic liver resection have been traditionally   Alternative treatment options include advanced imaging
          limited to Child’s A and early B cirrhotics. In recent   registration and catheter placement. In this current issue
          years, more sophisticated evaluations have been proposed   of Hepatoma Research, the role of laparoscopic ablation is
          including transjugular pressure gradients and vital dye   discussed and evaluated. Additional articles discuss the
          excretion. With the unfortunate limitations in transplantation   mechanism and role of sorafenib in the adjuvant and primary
          and resection, ablation has become the mainstay of therapy.   treatment of unresectable hepatocellular cancer .
          Chemoembolization and later radioembolization with yttrium
          have been most frequently employed a technique for ablation.  In the next decade, the number and incidence of unresectable
                                                              and untransplantable liver cancers will increase dramatically.
                          Access this article online          This necessitates improvements in loco-regional control
                                             Quick Response Code  including ablation technologies and adjuvant systemic
           Website:
                                                              therapies.
           http://www.hrjournal.net/
                                                                How to cite this article: Buell JF. The evolving role of laparoscopic ablation.
                                                                Hepatoma Res 2015;1:49.
           DOI:
           10.4103/2394-5079.159519
                                                                Source of Support: Nil. Confl ict of Interest: None declared.










               Hepatoma Research | Volume 1 | Issue 2 | July 15, 2015                                        49
   51   52   53   54   55   56   57   58   59   60   61